<code id='3802EE64BB'></code><style id='3802EE64BB'></style>
    • <acronym id='3802EE64BB'></acronym>
      <center id='3802EE64BB'><center id='3802EE64BB'><tfoot id='3802EE64BB'></tfoot></center><abbr id='3802EE64BB'><dir id='3802EE64BB'><tfoot id='3802EE64BB'></tfoot><noframes id='3802EE64BB'>

    • <optgroup id='3802EE64BB'><strike id='3802EE64BB'><sup id='3802EE64BB'></sup></strike><code id='3802EE64BB'></code></optgroup>
        1. <b id='3802EE64BB'><label id='3802EE64BB'><select id='3802EE64BB'><dt id='3802EE64BB'><span id='3802EE64BB'></span></dt></select></label></b><u id='3802EE64BB'></u>
          <i id='3802EE64BB'><strike id='3802EE64BB'><tt id='3802EE64BB'><pre id='3802EE64BB'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:53
          AI skin cancer detector, dermasensor. -- health tech coverage from STAT
          Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

          The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

          Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

          advertisement

          The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Trial using CRISPR to edit HIV out of cells disappoints
          Trial using CRISPR to edit HIV out of cells disappoints

          AdobeBALTIMORE—AnambitiousefforttocureHIVwithCRISPRgenomeeditingfellshortinanearlyclinicaltrial,inve

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Ohio train derailment: Experts on toxic chemical risks

          AblackplumerisesoverEastPalestine,Ohio,asaresultofacontrolleddetonationofaportionofthederailedNorfol